A Study to Evaluate the Efficacy, Safety and Tolerability of MIV-711 in Osteoarthritis Patients
Status:
Completed
Trial end date:
2017-05-23
Target enrollment:
Participant gender:
Summary
This is a multicentre, randomised, placebo-controlled, double-blind, three-arm parallel,
Phase IIa study to evaluate the efficacy, safety and tolerability of MIV-711 in patients with
knee osteoarthritis (OA).